enGenome offers the eVai platform, which utilizes AI and guideline-based classification to accurately interpret genomic variants for early diagnosis of rare diseases. This technology enhances clinical decision-making by providing precise genetic diagnoses, addressing the challenge of variant interpretation in translational research and routine healthcare.
Funding
Funding not disclosed
Founders
Product
Problem
Interpreting genomic variants is a significant bottleneck in the diagnosis of rare diseases, hindering timely and accurate clinical decision-making. Traditional methods often struggle with the complexity and volume of genomic data, leading to delays and potential misdiagnoses.
Solution
enGenome's eVai platform leverages artificial intelligence and guideline-based classification to streamline and enhance the interpretation of genomic variants, facilitating earlier and more precise diagnoses of rare diseases. The platform combines AI algorithms with established international guidelines to classify and prioritize genomic variants based on their pathogenicity, suggesting potential genetic diagnoses with improved accuracy. By automating and standardizing the variant interpretation process, eVai empowers clinicians to make more informed decisions, ultimately improving patient outcomes. The platform also offers VarChat, an open platform using Generative AI for literature summarization of genomic variants.
Target Audience
The primary target audience includes clinical geneticists, molecular diagnosticians, and translational researchers involved in the diagnosis and study of rare diseases.
Features
- AI-powered analysis for suggesting potential diagnoses based on genomic variants.
- Guideline-based classification adhering to international standards for variant interpretation.
- Continuous learning algorithms that improve accuracy and expand the knowledge base over time.
- Monogenic and digenic interpretation capabilities for comprehensive analysis.
- VarChat: Generative AI tool for searching genomic variants in literature and synthesizing information.